Q3 2024 |
443 |
$6.69B |
+$890M |
-$1.14B |
-$247M |
NUVL, VTRS, CNC, MRUS, OSCR
|
13F-HR |
11/14/2024, 04:01 PM |
Q2 2024 |
433 |
$6.01B |
+$1.12B |
-$578M |
+$543M |
NUVL, VTRS, CNC, MRUS, LRMR
|
13F-HR |
8/14/2024, 04:30 PM |
Q1 2024 |
367 |
$5.75B |
+$889M |
-$1.21B |
-$321M |
NUVL, VTRS, CNC, LRMR, AHCO
|
13F-HR |
5/15/2024, 04:00 PM |
Q4 2023 |
222 |
$5.42B |
+$583M |
-$688M |
-$106M |
NUVL, VTRS, CPRX, CNC, NBIX
|
13F-HR |
2/14/2024, 04:01 PM |
Q3 2023 |
88 |
$4.54B |
+$651M |
-$733M |
-$81.1M |
NUVL, VTRS, CNC, NBIX, AHCO
|
13F-HR |
11/14/2023, 04:01 PM |
Q2 2023 |
101 |
$4.68B |
+$468M |
-$720M |
-$252M |
NUVL, VTRS, AMED, AHCO, NBIX
|
13F-HR |
8/14/2023, 04:23 PM |
Q1 2023 |
106 |
$4.49B |
+$727M |
-$907M |
-$179M |
NUVL, NBIX, CPRX, VTRS, AHCO
|
13F-HR |
5/15/2023, 04:00 PM |
Q4 2022 |
104 |
$4.83B |
+$1.03B |
-$1.35B |
-$321M |
NUVL, NBIX, AHCO, VTRS, CPRX
|
13F-HR |
2/14/2023, 04:11 PM |
Q3 2022 |
126 |
$5.01B |
+$932M |
-$1.16B |
-$225M |
NUVL, NBIX, AHCO, SILK, CMAX
|
13F-HR |
11/14/2022, 04:27 PM |
Q2 2022 |
123 |
$4.75B |
+$1.03B |
-$307M |
+$724M |
NUVL, VTRS, AHCO, NBIX, SILK
|
13F-HR |
8/15/2022, 04:53 PM |
Q1 2022 |
118 |
$4.44B |
+$744M |
-$486M |
+$258M |
NUVL, VTRS, AHCO, NBIX, CMAX
|
13F-HR |
5/16/2022, 04:50 PM |
Q4 2021 |
125 |
$4.75B |
+$799M |
-$636M |
+$163M |
NUVL, VTRS, AHCO, CMAX, NBIX
|
13F-HR |
2/14/2022, 05:06 PM |
Q3 2021 |
132 |
$5.11B |
+$1.09B |
-$961M |
+$130M |
NUVL, VTRS, AHCO, CMAX, NBIX
|
13F-HR |
11/15/2021, 04:53 PM |
Q2 2021 |
143 |
$5.63B |
+$2.14B |
-$1.11B |
+$1.03B |
VTRS, OMIC, CMAX, AHCO, ORGO
|
13F-HR |
8/16/2021, 04:27 PM |
Q1 2021 |
133 |
$4.76B |
+$2.34B |
-$2.25B |
+$83.1M |
VTRS, EWTX, CNC, BSX, DFPH
|
13F-HR |
5/17/2021, 04:26 PM |
Q4 2020 |
129 |
$5.06B |
+$2.59B |
-$2.25B |
+$333M |
VTRS, GRAY, CNC, AFIB, LRMR
|
13F-HR |
2/16/2021, 04:23 PM |
Q3 2020 |
105 |
$4.11B |
+$1.68B |
-$1.26B |
+$425M |
MYL, IMMU, HZNP, AFIB, DFPHU
|
Restatement |
12/30/2020, 04:23 PM |
Q2 2020 |
93 |
$3.43B |
+$872M |
-$1.47B |
-$593M |
MYL, SDGR, DFPHU, HZNP, IMMU
|
13F-HR |
8/14/2020, 04:39 PM |
Q1 2020 |
90 |
$3.14B |
+$1.13B |
-$623M |
+$507M |
AHCO, MYL, HZNP, DFPHU, CNC
|
13F-HR |
5/15/2020, 04:13 PM |
Q4 2019 |
75 |
$3.13B |
+$691M |
-$671M |
+$19.4M |
AHCO, HZNP, MYL, ORTX, FIXX
|
13F-HR |
2/14/2020, 04:03 PM |
Q3 2019 |
94 |
$2.45B |
+$326M |
-$417M |
-$90.4M |
HZNP, MYL, ORTX, FIXX, AERI
|
13F-HR |
11/14/2019, 04:05 PM |
Q2 2019 |
96 |
$2.78B |
+$832M |
-$511M |
+$321M |
HZNP, MYL, ORTX, FIXX, AERI
|
13F-HR |
8/14/2019, 04:06 PM |
Q1 2019 |
93 |
$2.61B |
+$313M |
-$544M |
-$231M |
HZNP, FIXX, ORTX, PTLA, MYL
|
13F-HR |
5/15/2019, 04:31 PM |
Q4 2018 |
98 |
$2.46B |
+$570M |
-$460M |
+$110M |
HZNP, ORTX, FIXX, MYL, VCEL
|
13F-HR |
2/14/2019, 04:05 PM |
Q3 2018 |
102 |
$2.75B |
+$634M |
-$923M |
-$289M |
HZNP, FIXX, AERI, MYL, PTLA
|
13F-HR |
11/14/2018, 04:15 PM |
Q2 2018 |
113 |
$2.81B |
+$522M |
-$724M |
-$202M |
MNKKQ, HZNP, FIXX, MRTX, MYL
|
13F-HR |
8/14/2018, 04:30 PM |
Q1 2018 |
115 |
$2.82B |
+$798M |
-$540M |
+$258M |
MNKKQ, MYL, FIXX, HZNP, AVXS
|
13F-HR |
5/15/2018, 04:31 PM |
Q4 2017 |
97 |
$2.53B |
+$654M |
-$453M |
+$201M |
MNKKQ, MYL, HZNP, DXCM, GKOS
|
13F-HR |
2/14/2018, 04:20 PM |
Q3 2017 |
90 |
$2.21B |
+$672M |
-$396M |
+$276M |
AVXS, MCK, MYL, HZNP, GKOS
|
13F-HR |
11/13/2017, 11:38 AM |
Q2 2017 |
82 |
$1.81B |
+$232M |
-$1.02B |
-$787M |
AVXS, HZNP, NXTM, GILD, MYL
|
13F-HR |
8/14/2017, 04:02 PM |
Q1 2017 |
105 |
$2.58B |
+$529M |
-$689M |
-$160M |
AVXS, HZNP, NXTM, GILD, MYL
|
13F-HR |
5/15/2017, 04:03 PM |
Q4 2016 |
101 |
$2.41B |
+$647M |
-$217M |
+$430M |
HZNP, NXTM, AVXS, PTLA, GWPH
|
13F-HR |
2/14/2017, 05:03 PM |
Q3 2016 |
90 |
$2.15B |
+$232M |
-$976M |
-$744M |
GWPH, PTLA, HZNP, NXTM, AVXS
|
13F-HR |
11/14/2016, 04:29 PM |
Q2 2016 |
106 |
$2.54B |
+$500M |
-$461M |
+$39.3M |
HZNP, NXTM, GWPH, PTLA, AVXS
|
13F-HR |
8/15/2016, 10:22 AM |
Q1 2016 |
105 |
$2.33B |
+$746M |
-$405M |
+$341M |
HZNP, MYL, NXTM, GSK, AET
|
13F-HR |
5/16/2016, 04:05 PM |
Q4 2015 |
107 |
$2.38B |
+$370M |
-$686M |
-$316M |
HZNP, NXTM, DYAX, ADPTQ, GSK
|
13F-HR |
2/16/2016, 04:01 PM |
Q3 2015 |
133 |
$2.55B |
+$594M |
-$435M |
+$159M |
HZNP, NXTM, GSK, AET, FLML
|
13F-HR |
11/16/2015, 04:02 PM |
Q2 2015 |
119 |
$2.99B |
+$843M |
-$1.13B |
-$284M |
HZNP, FLML, NXTM, ARRY, DYAX
|
13F-HR |
8/14/2015, 04:18 PM |
Q1 2015 |
1 |
$1.04M |
$0 |
$0 |
|
|
New Holdings |
8/14/2015, 04:16 PM |
Q1 2015 |
121 |
$3.06B |
+$964M |
-$980M |
-$16M |
ASPX, HZNP, ABBV, NXTM, ARRY
|
13F-HR |
5/15/2015, 04:02 PM |
Q4 2014 |
106 |
$2.68B |
+$630M |
-$922M |
-$293M |
AUXL, ASPX, HZNP, AGN, FLML
|
13F-HR |
2/17/2015, 04:31 PM |
Q3 2014 |
121 |
$2.46B |
+$765M |
-$481M |
+$283M |
AUXL, AGN, NXTM, FLML, AAVL
|
13F-HR |
11/14/2014, 04:33 PM |
Q2 2014 |
117 |
$2.25B |
+$680M |
-$687M |
-$7.1M |
AUXL, ITMN, FLML, AGN, NXTM
|
13F-HR |
8/14/2014, 04:33 PM |
Q1 2014 |
115 |
$2.18B |
+$832M |
-$621M |
+$211M |
FLML, AUXL, LH, DRNA, QCOR
|
13F-HR |
5/15/2014, 04:31 PM |
Q4 2013 |
98 |
$1.77B |
$0 |
$0 |
|
AUXL, QCOR, ARRY, NXTM, INFI
|
13F-HR |
2/14/2014, 04:25 PM |